Evidence map›Paper›PMID 20074360›Full record

ArticleBMC neurology2010

Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study.

Alvaro Alonso, Giancarlo Logroscino, Susan S Jick, Miguel A Hernán

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. UK case control study of smoking and risk of amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2020
    Article
  11. Better survival in femaleTranslational neurodegeneration · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Alvaro AlonsoDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA. aalogut@alumni.unav.es
Giancarlo Logroscino
Susan S Jick
Miguel A Hernán
Boston Collaborative Drug Surveillance Program · USHarvard–MIT Division of Health Sciences and Technology · USUniversity of Bari Aldo Moro · ITUniversity of Minnesota · US

Funding

The Center for the Global Demography of AgingP30AG024409 · NIA · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BLOOM, DAVID E · 2004 to 2019
$7.9M
NIA NIH HHS P30 AG024409NIA NIH HHS P30AG024409-03
6 · The paper itself

Abstract

backgroundPrevious epidemiologic studies have examined the association of smoking with amyotrophic lateral sclerosis (ALS) incidence, but their results have been inconsistent. Moreover, limited information exists on the association between smoking and survival in ALS patients. We evaluated the association of smoking with ALS incidence and survival in a population-based cohort.

methodsWe conducted a case-control study nested in the General Practice Research Database, a computerized clinical database in the United Kingdom. Cases were 1143 individuals with a diagnosis of ALS; 11,371 matched controls were selected among GPRD participants free of ALS. Predictors of survival were determined in the ALS cases. Smoking information was obtained from the computer database.

resultsSmoking was not associated with the risk of ALS in this population. The rate ratio (RR) of ALS comparing ever versus never smokers was 1.04, 95% confidence interval (CI) 0.80-1.34. In analysis stratified by gender, however, ever smoking was associated with ALS in women (RR 1.53, 95% CI 1.04-2.23) but not in men (RR 0.75, 95% CI 0.53-1.06). Mortality was 71% after 2.1 average years of follow-up. Old age and female sex were associated with lower survival. Smoking was a predictor of mortality only in women. Comparing ever versus never smokers, RR (95% CI) of death was 1.31 (1.04-1.65) in women, and 0.90 (0.72-1.11) in men.

conclusionIn this large population-based study, smoking was associated with ALS risk and worse survival in women but not in men.

Indexed as

AdultAgedAged, 80 and overAge FactorsAmyotrophic Lateral SclerosisCase-Control StudiesCohort StudiesComputersDatabases, FactualFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk Factors

Identifiers

PMID20074360
PMCPMC2820482
OpenAlexW2125210805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.